London: British Prime Minister Boris Johnson welcomes the “Science Searchlight” who fought the “invisible enemy” COVID-19 with an approved Pfizer/Bioentech vaccine but urged the British public not to fall into “excessive optimism” I did.
In a 10 Downing Street briefing to ensure that the vaccine is ready to be distributed in the most dangerous categories by next week, Johnson stressed that it is still important for the country to follow a stratified COVID winter plan and stay vigilant to endure the long term. From a few months before the vaccination process begins in earnest early next year,
“We were waiting for the day that the science searchlight would find out our invisible enemies and give them the power to stop them from hurting us, and now scientists have done it.”
“When we celebrate this scientific achievement, it is even more important that we are not drawn to optimism or fall into naive belief that the struggle is over. We have to stick with our winter plans.” He said.
The Prime Minister, following the advice of the Independent Vaccinations and Vaccination Joint Committee (JCVI), confirmed that the first phase of vaccine deployment will include nursing home residents, health and nursing staff, the elderly, and those who are clinically extremely vulnerable. .
“But there is a huge logistics problem. The vaccine should be stored at -70 degrees Celsius, and each person should get two injections, three weeks apart. So it will take months before all of the most vulnerable are protected,” he said.
“[But] we are no longer settled in the simple hope that we can return to normal next spring, but rather settled in the sure and certain knowledge that we will succeed.”
His speech came a few hours after the UK government accepted the Independent Medicines and Medical Products Regulatory Authority (MHRA) evaluation and approved the use of Pfizer/Bioentech for COVID-19 vaccination.
Once approved, Pfizer will begin delivering vaccines to the UK. When recommending supply approval, MHRA will determine additional quality assurance tests that may be required before the vaccine is given, the Ministry of Health and Human Services said.
The UK claims to be the first country to pre-order a supply of vaccines from Pfizer/BioNTech, with 800,000 doses available next week and an overall order of 40 million doses to vaccinate up to a third of the population. The expected dosage in the first half of next year.
“As a nation, we owe a tremendous amount of gratitude to all scientists, clinicians and trial volunteers for winning against odds that sometimes seemed impossible. Britain became the first country thanks to their efforts and our Vaccine Task Force. We have signed a contract with Pfizer / BioNTech and will now be the first to distribute the vaccine. “Said Alok Sharma, British Business Secretary.
MHRA initiated a rolling review of Pfizer/BioNTech’s data in October, and the UK government asked regulatory agencies to assess whether the vaccine was eligible for approval under Regulation 174 of the Human Medicines Regulation, in response to a temporary supply of drugs. I made it possible to approve. Public health needs recommended by regulatory agencies.
The National Health Service (NHS), funded by the UK government, said the deployment plan will include NHS and its medical staff and a hospital hub where senior patients can be vaccinated. Community services that local teams and GPs have already registered to participate in the program And through vaccination centers across the country, it makes the vaccine accessible to people regardless of where they live.
“This vaccine has now passed all the extensive testing required for supply approval and will soon be ready for delivery to the NHS,” said Professor Jonathan Van-Tam, Deputy Medical Officer in the UK.
The vaccine will be available free of charge across the UK, and the government is said to be working with a mandated administration to ensure that it is deployed fairly in all four countries: Great Britain, Wales, Scotland and Northern Ireland.